Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (63 ops.)
Latest filing published 20 Oct 2025 for BeyondSpring Inc., €126k.
Filing timeline
BuySaleDecheng Capital China Life Sciences USD Fund III, L.P.
Insider track record
Disclosed buys
1
Disclosed sells
63
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Decheng Capital China Life Sciences USD Fund III, L.P.: trading record in brief
Decheng Capital China Life Sciences USD Fund III, L.P. is a declared insider at 3 companies; the most frequent names are BeyondSpring Inc., Alpine Immune Sciences, Inc. and Cue Health Inc. The record holds 68 filings, for trades running from 17 September 2021 to 17 October 2025.
On the open market, the record shows 1 purchase worth €12.3M and 63 sales worth €1.7M. Taken together, the purchases exceed the sales by €10.6M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 3 share grants. 2025 to date brings no purchases and 63 sales.
Most recently, on 20 October 2025, the filings show an open-market sale worth €68k in BeyondSpring Inc. The last insider purchase was made public on 21 September 2021, 1,859 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Decheng Capital China Life Sciences USD Fund III, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
85,798 shares@ US$1.7226.4% of flowOrdinary SharesSEC:0001231919-25-000335:0
107,361 shares@ US$1.7033.0% of flowOrdinary SharesSEC:0001231919-25-000323:0
7,507 shares@ US$1.772.4% of flowOrdinary SharesSEC:0001231919-25-000308:0
600 shares@ US$1.760.2% of flowOrdinary SharesSEC:0001231919-25-000292:0
17,500 shares@ US$1.785.6% of flowOrdinary SharesSEC:0001231919-25-000292:1
2,100 shares@ US$1.790.7% of flowOrdinary SharesSEC:0001231919-25-000292:2
4,464 shares@ US$1.811.4% of flowOrdinary SharesSEC:0001231919-25-000278:0
700 shares@ US$1.660.2% of flowOrdinary SharesSEC:0001231919-25-000258:0
5,410 shares@ US$1.831.8% of flowOrdinary SharesSEC:0001231919-25-000244:0
2,304 shares@ US$1.830.7% of flowOrdinary SharesSEC:0001231919-25-000221:0
700 shares@ US$1.850.2% of flowOrdinary SharesSEC:0001736814-25-000007:0
2,570 shares@ US$1.840.8% of flowOrdinary SharesSEC:0001736814-25-000007:1
840 shares@ US$1.880.3% of flowOrdinary SharesSEC:0001736814-25-000007:2
9,050 shares@ US$1.973.2% of flowOrdinary SharesSEC:0001415889-25-024317:0
803 shares@ US$1.820.3% of flowOrdinary SharesSEC:0001415889-25-023907:0
800 shares@ US$1.740.2% of flowOrdinary SharesSEC:0001415889-25-023607:0
2,000 shares@ US$1.790.6% of flowOrdinary SharesSEC:0001415889-25-023258:0
3,034 shares@ US$1.791.0% of flowOrdinary SharesSEC:0001415889-25-022967:0
47,668 shares@ US$2.0317.3% of flowOrdinary SharesSEC:0001415889-25-022532:0
2,000 shares@ US$2.000.7% of flowOrdinary SharesSEC:0001415889-25-022119:0
5,000 shares@ US$3.232.9% of flowOrdinary SharesSEC:0001415889-25-021441:0
1,234,636 shares@ US$12.7449.2% of flowCommon StockSEC:0001209191-24-002016:0
639,456 shares@ US$7.3516.3% of flowCommon StockSEC:0001209191-22-051370:0
1,360,544 shares@ US$7.3534.6% of flowCommon StockSEC:0001209191-22-051370:1
8,192,468 sharesCommon StockSEC:0001140361-21-033150:0
25 of 25 declarations
